Diabetes: New insulin sensitizers discovered

October 24, 2017, Columbia University Medical Center

A root cause of type 2 diabetes is a condition known as insulin resistance, in which cells stop responding to commands from the hormone that regulates glucose (sugar) storage. Restoring insulin sensitivity can be an effective strategy for preventing and treating diabetes, but the only insulin-sensitizing drugs on the market also stimulate the production of lipids (fats), which can lead to a number of serious side effects.

A new study, led by researchers at Columbia University Medical Center, indicates that it may be possible to improve while avoiding these adverse effects. The findings were published online in Cell.

Insulin, a hormone made in the pancreas, signals cells to grab glucose out of the bloodstream and use it for energy. When cells become resistant to insulin, glucose accumulates in the bloodstream. Eventually, insulin resistance can lead to diabetes.

"Researchers have been looking for ways to overcome insulin resistance without inadvertently triggering fat accumulation," said study leader Domenico Accili, MD, the Russell Berrie Foundation Professor of Diabetes and director of the Columbia University Diabetes Research Center at CUMC. "But previous efforts have been unsuccessful."

One approach that has been studied is to inhibit a protein called FOXO1. Animal studies have shown that when FOXO1 is suppressed, the liver makes less glucose. But like other insulin sensitizers, inhibiting FOXO1 also stimulates the production of lipids. "Thus, treatment of with a broadly acting FOXO1 inhibitor can lead to a host of unwanted side effects, such as weight gain," said Dr. Accili. "Unfortunately, with FOXO1 insulin sensitizers, you get the good with the bad."

In the current study, the researchers looked for a way to partially inhibit FOXO1 so that declined but lipid levels were unaffected. "What we needed to understand is how the two FOXO1-mediated mechanisms differ, so that we could identify selective inhibitors," said co-author Daniel Lindén, a scientist with AstraZeneca's Innovative Medicines and Early Development biotech Unit in Gothenburg, Sweden.

In studies performed in mice, Dr. Accili and his colleagues discovered that FOXO1 works with a protein called SIN3A to limit lipid production. "This suggested that if we could find molecules that act on the glucose-production arm of FOXO1 while leaving SIN3A alone, we could improve insulin sensitivity and lower blood sugar without increasing fat," said Dr. Accili.

From a screen of one million small molecules, the team identified several with the desired effect in liver cells. They went on to characterize three of these molecules in greater detail—potentially paving the way for the development of a new class of sensitizers.

"The next step is to optimize these compounds for animal testing and lay the groundwork for clinical trials," said Dr. Accili. "We're excited by the possibility of developing a new and safer way to treat ."

Explore further: A new approach to treating type I diabetes? Gut cells transformed into insulin factories

More information: Cell (2017). DOI: 10.1016/j.cell.2017

Related Stories

A new approach to treating type I diabetes? Gut cells transformed into insulin factories

March 11, 2012
A study by Columbia researchers suggests that cells in the patient's intestine could be coaxed into making insulin, circumventing the need for a stem cell transplant. Until now, stem cell transplants have been seen by many ...

Study explains decrease in insulin-producing beta cells in diabetes

September 13, 2012
Scientists generally think that reduced insulin production by the pancreas, a hallmark of type 2 diabetes, is due to the death of the organ's beta cells. However, a new study by Columbia University Medical Center (CUMC) researchers ...

Intestinal glucose stimulation has anti-incretin effect

September 13, 2017
(HealthDay)—Intestinal glucose stimulation has an anti-incretin effect, down regulating insulin sensitivity, according to a study published online Aug. 29 in Diabetes.

It may take guts to cure diabetes: Human GI cells retrained to produce insulin

June 30, 2014
By switching off a single gene, scientists at Columbia University's Naomi Berrie Diabetes Center have converted human gastrointestinal cells into insulin-producing cells, demonstrating in principle that a drug could retrain ...

Insulin signaling molecule in liver controls levels of triglyceride in blood

October 19, 2017
A new animal study shows how insulin controls the movement and storage of fat molecules in the liver and how a breakdown in this system could lead to non-alcoholic fatty liver disease and changes in circulating lipid levels ...

Study reveals how FOXO1 slows diabetic wound healing

April 27, 2015
A protein that normally fosters tissue repair instead acts to inhibit healing when sugar levels are high, according to a study in The Journal of Cell Biology. The role reversal helps explain why wounds heal slowly in people ...

Recommended for you

Using mushrooms as a prebiotic may help improve glucose regulation

August 16, 2018
Eating white button mushrooms can create subtle shifts in the microbial community in the gut, which could improve the regulation of glucose in the liver, according to a team of researchers. They also suggest that better understanding ...

Cardiovascular disease related to type 2 diabetes can be reduced significantly

August 16, 2018
Properly composed treatment and refraining from cigarette consumption can significantly reduce the risk of cardiovascular disease resulting from type 2 diabetes, according to a study published in the New England Journal of ...

Blood test may identify gestational diabetes risk in first trimester

August 16, 2018
A blood test conducted as early as the 10th week of pregnancy may help identify women at risk for gestational diabetes, a pregnancy-related condition that poses potentially serious health risks for mothers and infants, according ...

Weight gain after smoking cessation linked to increased short-term diabetes risk

August 15, 2018
People who gain weight after they quit smoking may face a temporary increase in the risk of developing type 2 diabetes, with the risk directly proportional to the weight gain, according to a new study from Harvard T.H. Chan ...

Evening preference, lack of sleep associated with higher BMI in people with prediabetes

August 15, 2018
People with prediabetes who go to bed later, eat meals later and are more active and alert later in the day—those who have an "evening preference"—have higher body mass indices compared with people with prediabetes who ...

Healthy fat cells uncouple obesity from diabetes

August 14, 2018
About 422 million people around the world, including more than 30 million Americans, have diabetes. Approximately ninety percent of them have type 2 diabetes. People with this condition cannot effectively use insulin, a hormone ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.